APO Research
Talk to an analyst

APO RESEARCH · REPORT

Coronavirus Treatment Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Coronavirus Treatment Drugs Industry Growth and Trends Forecast to 2032

20 December 2025110 pages

Choose your research edition.

Industry ResearchCoronavirus Treatment Drugs Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Coronavirus Treatment Drugs Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Coronavirus Treatment Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Coronavirus Treatment Drugs Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Coronavirus Treatment Drugs Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

According to APO Research, the global Coronavirus Treatment Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Coronavirus Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Coronavirus Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Coronavirus Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Coronavirus Treatment Drugs market include Bharat Biotech International Limited, Cadila Healthcare Limited, CanSino Biologics, Celltrion Healthcare, Dr. Reddy's Laboratories, Gilead Sciences, Glenmark Pharmaceuticals Limited, Moderna and Novavax, Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Coronavirus Treatment Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Coronavirus Treatment Drugs market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Coronavirus Treatment Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Coronavirus Treatment Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Coronavirus Treatment Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Coronavirus Treatment Drugs Market by Company

Bharat Biotech International Limited

Cadila Healthcare Limited

CanSino Biologics

Celltrion Healthcare

Dr. Reddy's Laboratories

Gilead Sciences

Glenmark Pharmaceuticals Limited

Moderna

Novavax, Inc

Serum Institute of India

Sinovac Biotech

Sorrento Therapeutics

AstraZeneca Plc

GlaxoSmithKline Plc

Pfizer Inc

Eli Lilly and Company

Roche

Merck & Co., Inc

Johnson & Johnson

Coronavirus Treatment Drugs Segment by Type

Monoclonal Antibodies

Kinase Inhibitors

Anti-viral

Corticosteroids

Others

Coronavirus Treatment Drugs Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Coronavirus Treatment Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Coronavirus Treatment Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Coronavirus Treatment Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Coronavirus Treatment Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Coronavirus Treatment Drugs companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Coronavirus Treatment Drugs Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Coronavirus Treatment Drugs Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Coronavirus Treatment Drugs Market Share by Region (2021-2026) Table 4. Global Coronavirus Treatment Drugs Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Coronavirus Treatment Drugs Market Share by Region (2027-2032) Table 6. Global Coronavirus Treatment Drugs Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Coronavirus Treatment Drugs Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Coronavirus Treatment Drugs Market Size Share by Type (2021-2026) Table 9. Global Coronavirus Treatment Drugs Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Coronavirus Treatment Drugs Market Size Share Forecasted by Type (2027-2032) Table 11. North America Coronavirus Treatment Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Coronavirus Treatment Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Coronavirus Treatment Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Coronavirus Treatment Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Coronavirus Treatment Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Coronavirus Treatment Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Coronavirus Treatment Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Coronavirus Treatment Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Coronavirus Treatment Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Coronavirus Treatment Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Coronavirus Treatment Drugs Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Coronavirus Treatment Drugs Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Coronavirus Treatment Drugs Market Size Share by Application (2021-2026) Table 24. Global Coronavirus Treatment Drugs Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Coronavirus Treatment Drugs Market Size Share Forecasted by Application (2027-2032) Table 26. North America Coronavirus Treatment Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Coronavirus Treatment Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Coronavirus Treatment Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Coronavirus Treatment Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Coronavirus Treatment Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Coronavirus Treatment Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Coronavirus Treatment Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Coronavirus Treatment Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Coronavirus Treatment Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Coronavirus Treatment Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Coronavirus Treatment Drugs Industry Trends Table 37. Coronavirus Treatment Drugs Industry Drivers Table 38. Coronavirus Treatment Drugs Industry Opportunities and Challenges Table 39. Coronavirus Treatment Drugs Industry Restraints Table 40. Global Coronavirus Treatment Drugs Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Coronavirus Treatment Drugs Revenue Market Share by Company (2021-2026) Table 42. Global Coronavirus Treatment Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Coronavirus Treatment Drugs Key Company Headquarters & Area Served Table 44. Global Coronavirus Treatment Drugs Company, Product Type & Application Table 45. Global Coronavirus Treatment Drugs Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Coronavirus Treatment Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Bharat Biotech International Limited Company Information Table 49. Bharat Biotech International Limited Business Overview Table 50. Bharat Biotech International Limited Coronavirus Treatment Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Bharat Biotech International Limited Coronavirus Treatment Drugs Product Portfolio Table 52. Bharat Biotech International Limited Recent Development Table 53. Cadila Healthcare Limited Company Information Table 54. Cadila Healthcare Limited Business Overview Table 55. Cadila Healthcare Limited Coronavirus Treatment Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Cadila Healthcare Limited Coronavirus Treatment Drugs Product Portfolio Table 57. Cadila Healthcare Limited Recent Development Table 58. CanSino Biologics Company Information Table 59. CanSino Biologics Business Overview Table 60. CanSino Biologics Coronavirus Treatment Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. CanSino Biologics Coronavirus Treatment Drugs Product Portfolio Table 62. CanSino Biologics Recent Development Table 63. Celltrion Healthcare Company Information Table 64. Celltrion Healthcare Business Overview Table 65. Celltrion Healthcare Coronavirus Treatment Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Celltrion Healthcare Coronavirus Treatment Drugs Product Portfolio Table 67. Celltrion Healthcare Recent Development Table 68. Dr. Reddy's Laboratories Company Information Table 69. Dr. Reddy's Laboratories Business Overview Table 70. Dr. Reddy's Laboratories Coronavirus Treatment Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Dr. Reddy's Laboratories Coronavirus Treatment Drugs Product Portfolio Table 72. Dr. Reddy's Laboratories Recent Development Table 73. Gilead Sciences Company Information Table 74. Gilead Sciences Business Overview Table 75. Gilead Sciences Coronavirus Treatment Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Gilead Sciences Coronavirus Treatment Drugs Product Portfolio Table 77. Gilead Sciences Recent Development Table 78. Glenmark Pharmaceuticals Limited Company Information Table 79. Glenmark Pharmaceuticals Limited Business Overview Table 80. Glenmark Pharmaceuticals Limited Coronavirus Treatment Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Glenmark Pharmaceuticals Limited Coronavirus Treatment Drugs Product Portfolio Table 82. Glenmark Pharmaceuticals Limited Recent Development Table 83. Moderna Company Information Table 84. Moderna Business Overview Table 85. Moderna Coronavirus Treatment Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Moderna Coronavirus Treatment Drugs Product Portfolio Table 87. Moderna Recent Development Table 88. Novavax, Inc Company Information Table 89. Novavax, Inc Business Overview Table 90. Novavax, Inc Coronavirus Treatment Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Novavax, Inc Coronavirus Treatment Drugs Product Portfolio Table 92. Novavax, Inc Recent Development Table 93. Serum Institute of India Company Information Table 94. Serum Institute of India Business Overview Table 95. Serum Institute of India Coronavirus Treatment Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Serum Institute of India Coronavirus Treatment Drugs Product Portfolio Table 97. Serum Institute of India Recent Development Table 98. Sinovac Biotech Company Information Table 99. Sinovac Biotech Business Overview Table 100. Sinovac Biotech Coronavirus Treatment Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Sinovac Biotech Coronavirus Treatment Drugs Product Portfolio Table 102. Sinovac Biotech Recent Development Table 103. Sorrento Therapeutics Company Information Table 104. Sorrento Therapeutics Business Overview Table 105. Sorrento Therapeutics Coronavirus Treatment Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Sorrento Therapeutics Coronavirus Treatment Drugs Product Portfolio Table 107. Sorrento Therapeutics Recent Development Table 108. AstraZeneca Plc Company Information Table 109. AstraZeneca Plc Business Overview Table 110. AstraZeneca Plc Coronavirus Treatment Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. AstraZeneca Plc Coronavirus Treatment Drugs Product Portfolio Table 112. AstraZeneca Plc Recent Development Table 113. GlaxoSmithKline Plc Company Information Table 114. GlaxoSmithKline Plc Business Overview Table 115. GlaxoSmithKline Plc Coronavirus Treatment Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. GlaxoSmithKline Plc Coronavirus Treatment Drugs Product Portfolio Table 117. GlaxoSmithKline Plc Recent Development Table 118. Pfizer Inc Company Information Table 119. Pfizer Inc Business Overview Table 120. Pfizer Inc Coronavirus Treatment Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Pfizer Inc Coronavirus Treatment Drugs Product Portfolio Table 122. Pfizer Inc Recent Development Table 123. Eli Lilly and Company Company Information Table 124. Eli Lilly and Company Business Overview Table 125. Eli Lilly and Company Coronavirus Treatment Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Eli Lilly and Company Coronavirus Treatment Drugs Product Portfolio Table 127. Eli Lilly and Company Recent Development Table 128. Roche Company Information Table 129. Roche Business Overview Table 130. Roche Coronavirus Treatment Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Roche Coronavirus Treatment Drugs Product Portfolio Table 132. Roche Recent Development Table 133. Merck & Co., Inc Company Information Table 134. Merck & Co., Inc Business Overview Table 135. Merck & Co., Inc Coronavirus Treatment Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Merck & Co., Inc Coronavirus Treatment Drugs Product Portfolio Table 137. Merck & Co., Inc Recent Development Table 138. Johnson & Johnson Company Information Table 139. Johnson & Johnson Business Overview Table 140. Johnson & Johnson Coronavirus Treatment Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Johnson & Johnson Coronavirus Treatment Drugs Product Portfolio Table 142. Johnson & Johnson Recent Development Table 143. North America Coronavirus Treatment Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. North America Coronavirus Treatment Drugs Market Size by Country (2021-2026) & (US$ Million) Table 145. North America Coronavirus Treatment Drugs Market Share by Country (2021-2026) Table 146. North America Coronavirus Treatment Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. North America Coronavirus Treatment Drugs Market Share Forecast by Country (2027-2032) Table 148. Europe Coronavirus Treatment Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Europe Coronavirus Treatment Drugs Market Size by Country (2021-2026) & (US$ Million) Table 150. Europe Coronavirus Treatment Drugs Market Share by Country (2021-2026) Table 151. Europe Coronavirus Treatment Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Europe Coronavirus Treatment Drugs Market Share Forecast by Country (2027-2032) Table 153. Asia-Pacific Coronavirus Treatment Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Asia-Pacific Coronavirus Treatment Drugs Market Size by Country (2021-2026) & (US$ Million) Table 155. Asia-Pacific Coronavirus Treatment Drugs Market Share by Country (2021-2026) Table 156. Asia-Pacific Coronavirus Treatment Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Asia-Pacific Coronavirus Treatment Drugs Market Share Forecast by Country (2027-2032) Table 158. Latin America Coronavirus Treatment Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Latin America Coronavirus Treatment Drugs Market Size by Country (2021-2026) & (US$ Million) Table 160. Latin America Coronavirus Treatment Drugs Market Share by Country (2021-2026) Table 161. Latin America Coronavirus Treatment Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Latin America Coronavirus Treatment Drugs Market Share Forecast by Country (2027-2032) Table 163. Middle East & Africa Coronavirus Treatment Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Middle East & Africa Coronavirus Treatment Drugs Market Size by Country (2021-2026) & (US$ Million) Table 165. Middle East & Africa Coronavirus Treatment Drugs Market Share by Country (2021-2026) Table 166. Middle East & Africa Coronavirus Treatment Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Middle East & Africa Coronavirus Treatment Drugs Market Share Forecast by Country (2027-2032) Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Coronavirus Treatment Drugs Product Image Figure 3. Global Coronavirus Treatment Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Coronavirus Treatment Drugs Market Size (2021-2032) & (US$ Million) Figure 5. Global Coronavirus Treatment Drugs Market Share by Region: 2025 VS 2032 Figure 6. Global Coronavirus Treatment Drugs Market Share by Region (2021-2032) Figure 7. North America Coronavirus Treatment Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Coronavirus Treatment Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Coronavirus Treatment Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Coronavirus Treatment Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Coronavirus Treatment Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Monoclonal Antibodies Image Figure 13. Global Monoclonal Antibodies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Kinase Inhibitors Image Figure 15. Global Kinase Inhibitors Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Anti-viral Image Figure 17. Global Anti-viral Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Corticosteroids Image Figure 19. Global Corticosteroids Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Others Image Figure 21. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Global Coronavirus Treatment Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 23. Global Coronavirus Treatment Drugs Market Share by Type 2025 VS 2032 Figure 24. North America Coronavirus Treatment Drugs Market Size Share by Type (2021-2032) Figure 25. Europe Coronavirus Treatment Drugs Market Size Share by Type (2021-2032) Figure 26. Asia-Pacific Coronavirus Treatment Drugs Market Size Share by Type (2021-2032) Figure 27. Latin America Coronavirus Treatment Drugs Market Size Share by Type (2021-2032) Figure 28. Middle East and Africa Coronavirus Treatment Drugs Market Size Share by Type (2021-2032) Figure 29. Retail Pharmacies Image Figure 30. Global Retail Pharmacies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Online Pharmacies Image Figure 32. Global Online Pharmacies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Hospital Pharmacies Image Figure 34. Global Hospital Pharmacies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Coronavirus Treatment Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Coronavirus Treatment Drugs Market Share by Application 2025 VS 2032 Figure 37. North America Coronavirus Treatment Drugs Market Size Share by Application (2021-2032) Figure 38. Europe Coronavirus Treatment Drugs Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Coronavirus Treatment Drugs Market Size Share by Application (2021-2032) Figure 40. Latin America Coronavirus Treatment Drugs Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Coronavirus Treatment Drugs Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Coronavirus Treatment Drugs Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Coronavirus Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Coronavirus Treatment Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Coronavirus Treatment Drugs Market Share by Country (2021-2032) Figure 47. Europe Coronavirus Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Coronavirus Treatment Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Coronavirus Treatment Drugs Market Share by Country (2021-2032) Figure 50. Asia-Pacific Coronavirus Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Coronavirus Treatment Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Coronavirus Treatment Drugs Market Share by Country (2021-2032) Figure 53. Latin America Coronavirus Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Coronavirus Treatment Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Coronavirus Treatment Drugs Market Share by Country (2021-2032) Figure 56. Middle East & Africa Coronavirus Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Coronavirus Treatment Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Coronavirus Treatment Drugs Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • Monoclonal Antibodies
  • Kinase Inhibitors
  • Anti-viral
  • Corticosteroids
  • Others
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Bharat Biotech International Limited
  • Cadila Healthcare Limited
  • CanSino Biologics
  • Celltrion Healthcare
  • Dr. Reddy's Laboratories
  • Gilead Sciences
  • Glenmark Pharmaceuticals Limited
  • Moderna
  • Novavax, Inc
  • Serum Institute of India
  • Sinovac Biotech
  • Sorrento Therapeutics
  • AstraZeneca Plc
  • GlaxoSmithKline Plc
  • Pfizer Inc
  • Eli Lilly and Company
  • Roche
  • Merck & Co., Inc
  • Johnson & Johnson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Coronavirus Treatment Drugs Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Coronavirus Treatment Drugs Market Size by Region (2021-2032)
  5. 1.4.1 Global Coronavirus Treatment Drugs Market Size by Region (2021-2026)
  6. 1.4.2 Global Coronavirus Treatment Drugs Market Size by Region (2027-2032)
  7. 1.5 Key Regions Coronavirus Treatment Drugs Market Size (2021-2032)
  8. 1.5.1 North America Coronavirus Treatment Drugs Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Coronavirus Treatment Drugs Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Coronavirus Treatment Drugs Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Coronavirus Treatment Drugs Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Coronavirus Treatment Drugs Market Size Growth Rate (2021-2032)
2 Coronavirus Treatment Drugs Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Monoclonal Antibodies
  3. 2.1.2 Kinase Inhibitors
  4. 2.1.3 Anti-viral
  5. 2.1.4 Corticosteroids
  6. 2.1.5 Others
  7. 2.2 Global Coronavirus Treatment Drugs Market Size by Type
  8. 2.2.1 Global Coronavirus Treatment Drugs Market Size Overview by Type (2021-2032)
  9. 2.2.2 Global Coronavirus Treatment Drugs Historic Market Size Review by Type (2021-2026)
  10. 2.2.3 Global Coronavirus Treatment Drugs Market Size Forecasted by Type (2027-2032)
  11. 2.3 Global Coronavirus Treatment Drugs Market Size by Regions
  12. 2.3.1 North America Coronavirus Treatment Drugs Market Size Breakdown by Type (2021-2026)
  13. 2.3.2 Europe Coronavirus Treatment Drugs Market Size Breakdown by Type (2021-2026)
  14. 2.3.3 Asia-Pacific Coronavirus Treatment Drugs Market Size Breakdown by Type (2021-2026)
  15. 2.3.4 South America Coronavirus Treatment Drugs Market Size Breakdown by Type (2021-2026)
  16. 2.3.5 Middle East and Africa Coronavirus Treatment Drugs Market Size Breakdown by Type (2021-2026)
3 Coronavirus Treatment Drugs Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Retail Pharmacies
  3. 3.1.2 Online Pharmacies
  4. 3.1.3 Hospital Pharmacies
  5. 3.2 Global Coronavirus Treatment Drugs Market Size by Application
  6. 3.2.1 Global Coronavirus Treatment Drugs Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Coronavirus Treatment Drugs Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Coronavirus Treatment Drugs Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Coronavirus Treatment Drugs Market Size by Regions
  10. 3.3.1 North America Coronavirus Treatment Drugs Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Coronavirus Treatment Drugs Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Coronavirus Treatment Drugs Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Coronavirus Treatment Drugs Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Coronavirus Treatment Drugs Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Coronavirus Treatment Drugs Industry Trends
  2. 4.2 Coronavirus Treatment Drugs Industry Drivers
  3. 4.3 Coronavirus Treatment Drugs Industry Opportunities and Challenges
  4. 4.4 Coronavirus Treatment Drugs Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Coronavirus Treatment Drugs Revenue (2021-2026)
  2. 5.2 Global Coronavirus Treatment Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Coronavirus Treatment Drugs Key Company Headquarters & Area Served
  4. 5.4 Global Coronavirus Treatment Drugs Company, Product Type & Application
  5. 5.5 Global Coronavirus Treatment Drugs Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Coronavirus Treatment Drugs Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Coronavirus Treatment Drugs Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Coronavirus Treatment Drugs Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Bharat Biotech International Limited
  2. 6.1.1 Bharat Biotech International Limited Company Information
  3. 6.1.2 Bharat Biotech International Limited Business Overview
  4. 6.1.3 Bharat Biotech International Limited Coronavirus Treatment Drugs Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Bharat Biotech International Limited Coronavirus Treatment Drugs Product Portfolio
  6. 6.1.5 Bharat Biotech International Limited Recent Developments
  7. 6.2 Cadila Healthcare Limited
  8. 6.2.1 Cadila Healthcare Limited Company Information
  9. 6.2.2 Cadila Healthcare Limited Business Overview
  10. 6.2.3 Cadila Healthcare Limited Coronavirus Treatment Drugs Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Cadila Healthcare Limited Coronavirus Treatment Drugs Product Portfolio
  12. 6.2.5 Cadila Healthcare Limited Recent Developments
  13. 6.3 CanSino Biologics
  14. 6.3.1 CanSino Biologics Company Information
  15. 6.3.2 CanSino Biologics Business Overview
  16. 6.3.3 CanSino Biologics Coronavirus Treatment Drugs Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 CanSino Biologics Coronavirus Treatment Drugs Product Portfolio
  18. 6.3.5 CanSino Biologics Recent Developments
  19. 6.4 Celltrion Healthcare
  20. 6.4.1 Celltrion Healthcare Company Information
  21. 6.4.2 Celltrion Healthcare Business Overview
  22. 6.4.3 Celltrion Healthcare Coronavirus Treatment Drugs Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Celltrion Healthcare Coronavirus Treatment Drugs Product Portfolio
  24. 6.4.5 Celltrion Healthcare Recent Developments
  25. 6.5 Dr. Reddy's Laboratories
  26. 6.5.1 Dr. Reddy's Laboratories Company Information
  27. 6.5.2 Dr. Reddy's Laboratories Business Overview
  28. 6.5.3 Dr. Reddy's Laboratories Coronavirus Treatment Drugs Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Dr. Reddy's Laboratories Coronavirus Treatment Drugs Product Portfolio
  30. 6.5.5 Dr. Reddy's Laboratories Recent Developments
  31. 6.6 Gilead Sciences
  32. 6.6.1 Gilead Sciences Company Information
  33. 6.6.2 Gilead Sciences Business Overview
  34. 6.6.3 Gilead Sciences Coronavirus Treatment Drugs Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Gilead Sciences Coronavirus Treatment Drugs Product Portfolio
  36. 6.6.5 Gilead Sciences Recent Developments
  37. 6.7 Glenmark Pharmaceuticals Limited
  38. 6.7.1 Glenmark Pharmaceuticals Limited Company Information
  39. 6.7.2 Glenmark Pharmaceuticals Limited Business Overview
  40. 6.7.3 Glenmark Pharmaceuticals Limited Coronavirus Treatment Drugs Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Glenmark Pharmaceuticals Limited Coronavirus Treatment Drugs Product Portfolio
  42. 6.7.5 Glenmark Pharmaceuticals Limited Recent Developments
  43. 6.8 Moderna
  44. 6.8.1 Moderna Company Information
  45. 6.8.2 Moderna Business Overview
  46. 6.8.3 Moderna Coronavirus Treatment Drugs Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Moderna Coronavirus Treatment Drugs Product Portfolio
  48. 6.8.5 Moderna Recent Developments
  49. 6.9 Novavax, Inc
  50. 6.9.1 Novavax, Inc Company Information
  51. 6.9.2 Novavax, Inc Business Overview
  52. 6.9.3 Novavax, Inc Coronavirus Treatment Drugs Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Novavax, Inc Coronavirus Treatment Drugs Product Portfolio
  54. 6.9.5 Novavax, Inc Recent Developments
  55. 6.10 Serum Institute of India
  56. 6.10.1 Serum Institute of India Company Information
  57. 6.10.2 Serum Institute of India Business Overview
  58. 6.10.3 Serum Institute of India Coronavirus Treatment Drugs Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Serum Institute of India Coronavirus Treatment Drugs Product Portfolio
  60. 6.10.5 Serum Institute of India Recent Developments
  61. 6.11 Sinovac Biotech
  62. 6.11.1 Sinovac Biotech Company Information
  63. 6.11.2 Sinovac Biotech Business Overview
  64. 6.11.3 Sinovac Biotech Coronavirus Treatment Drugs Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Sinovac Biotech Coronavirus Treatment Drugs Product Portfolio
  66. 6.11.5 Sinovac Biotech Recent Developments
  67. 6.12 Sorrento Therapeutics
  68. 6.12.1 Sorrento Therapeutics Company Information
  69. 6.12.2 Sorrento Therapeutics Business Overview
  70. 6.12.3 Sorrento Therapeutics Coronavirus Treatment Drugs Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Sorrento Therapeutics Coronavirus Treatment Drugs Product Portfolio
  72. 6.12.5 Sorrento Therapeutics Recent Developments
  73. 6.13 AstraZeneca Plc
  74. 6.13.1 AstraZeneca Plc Company Information
  75. 6.13.2 AstraZeneca Plc Business Overview
  76. 6.13.3 AstraZeneca Plc Coronavirus Treatment Drugs Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 AstraZeneca Plc Coronavirus Treatment Drugs Product Portfolio
  78. 6.13.5 AstraZeneca Plc Recent Developments
  79. 6.14 GlaxoSmithKline Plc
  80. 6.14.1 GlaxoSmithKline Plc Company Information
  81. 6.14.2 GlaxoSmithKline Plc Business Overview
  82. 6.14.3 GlaxoSmithKline Plc Coronavirus Treatment Drugs Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 GlaxoSmithKline Plc Coronavirus Treatment Drugs Product Portfolio
  84. 6.14.5 GlaxoSmithKline Plc Recent Developments
  85. 6.15 Pfizer Inc
  86. 6.15.1 Pfizer Inc Company Information
  87. 6.15.2 Pfizer Inc Business Overview
  88. 6.15.3 Pfizer Inc Coronavirus Treatment Drugs Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Pfizer Inc Coronavirus Treatment Drugs Product Portfolio
  90. 6.15.5 Pfizer Inc Recent Developments
  91. 6.16 Eli Lilly and Company
  92. 6.16.1 Eli Lilly and Company Company Information
  93. 6.16.2 Eli Lilly and Company Business Overview
  94. 6.16.3 Eli Lilly and Company Coronavirus Treatment Drugs Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Eli Lilly and Company Coronavirus Treatment Drugs Product Portfolio
  96. 6.16.5 Eli Lilly and Company Recent Developments
  97. 6.17 Roche
  98. 6.17.1 Roche Company Information
  99. 6.17.2 Roche Business Overview
  100. 6.17.3 Roche Coronavirus Treatment Drugs Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Roche Coronavirus Treatment Drugs Product Portfolio
  102. 6.17.5 Roche Recent Developments
  103. 6.18 Merck & Co., Inc
  104. 6.18.1 Merck & Co., Inc Company Information
  105. 6.18.2 Merck & Co., Inc Business Overview
  106. 6.18.3 Merck & Co., Inc Coronavirus Treatment Drugs Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Merck & Co., Inc Coronavirus Treatment Drugs Product Portfolio
  108. 6.18.5 Merck & Co., Inc Recent Developments
  109. 6.19 Johnson & Johnson
  110. 6.19.1 Johnson & Johnson Company Information
  111. 6.19.2 Johnson & Johnson Business Overview
  112. 6.19.3 Johnson & Johnson Coronavirus Treatment Drugs Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Johnson & Johnson Coronavirus Treatment Drugs Product Portfolio
  114. 6.19.5 Johnson & Johnson Recent Developments
7 North America
  1. 7.1 North America Coronavirus Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Coronavirus Treatment Drugs Market Size by Country (2021-2026)
  3. 7.3 North America Coronavirus Treatment Drugs Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Coronavirus Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Coronavirus Treatment Drugs Market Size by Country (2021-2026)
  3. 8.3 Europe Coronavirus Treatment Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Coronavirus Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Coronavirus Treatment Drugs Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Coronavirus Treatment Drugs Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Coronavirus Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Coronavirus Treatment Drugs Market Size by Country (2021-2026)
  3. 10.3 South America Coronavirus Treatment Drugs Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Coronavirus Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Coronavirus Treatment Drugs Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Coronavirus Treatment Drugs Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst